Conclusively, they suggested that AR-circHIAT1 -mediated miR-195-5p/29a-3p/29c-3p/CDC42 axis may give us novel insights into develop new therapies to cure ccRCC [66]. This evidence concerns the gene CDC42 and nonpapillary renal cell carcinoma.